1 / 8

U.S. Drug Delivery Technology Markets Meeting Specialized Technologies’ Challenges Defines Market Winners

U.S. Drug Delivery Technology Markets Meeting Specialized Technologies’ Challenges Defines Market Winners.

liseli
Télécharger la présentation

U.S. Drug Delivery Technology Markets Meeting Specialized Technologies’ Challenges Defines Market Winners

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Drug Delivery Technology MarketsMeeting Specialized Technologies’ Challenges Defines Market Winners "Competitive drug delivery markets are being transformed from low-risk to high-risk businesses. In the past, companies focused on oral controlled release systems, which generally ensured positive revenues. But mounting competition has forced companies to shift their efforts to alternative delivery routes, such as intranasal or lingual delivery." Pharmaceuticals Analyst Team Frost & Sullivan

  2. Key Features • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analytical insights into current topics and emerging • applications in the drug delivery market • Market-sizing and competitive analysis • Market forecasts and opportunity analyses • Quarterly assessments • End-user analysis

  3. What We Offer • Coverage: The United States • Proven methodology using extensive primary and secondary data as well as research • Focused information and strategies that cover business and technology issues • Credible data and analyses that highlight industry dynamics • Precise strategies to help you create winning business plans

  4. Who Will Benefit? Current Market Participants • Find out where you stand in comparison with the competitors • Assess current and future drivers as well as restraints • Determine and exploit new market share opportunities New Entrants • Analyze the associated challenges • Calculate timescales for strategy implementation • Position yourself to capitalize on the unmet needs of the market Investment Community • Analyze long-term strategies of companies • Determine which participants will outperform the competition • Assess the attractiveness of investing in the market

  5. Key Market Participants 3M Advanced Polymer Aerogen, Inc. AHP/Wyeth Alkermes, Inc. Alza Corp. Amgen, Inc. Andrx Corp. Anika Therapeutics, Inc. Aradigm Corp. Atrix Laboratories, Inc. Aventis Pharmaceuticals, Inc. Baxa Corp. Becton Dickinson & Co. Bioject Medical Technologies, Inc. Biogel Bioprogress Technology Biovail Corp. Cellegy Pharmaceuticals, Inc. Cephalon/Anesta Chiron Corp. Cima Labs Columbia Laboratories, Inc. Cygnus, Inc. Depotech/Skyepharma Discovery Therapeutics, Inc. Dupont Dura/Elan Duramed Pharmaceuticals, Inc. Elan Corp. Eli Lilly & Co. Elite Pharmaceuticals, Inc. Emisphere Technologies, Inc. Endorex Corp.

  6. Key Market Participants (cont’d) Enzon, Inc. Epic Therapeutics, Inc. Epicyte Pharmaceuticals, Inc Equidyne Systems FeRx, Inc. Flemigton Pharmaceutical Corp. Fournier Research, Inc. Fuisz/Biovail Genta, Inc. Genetronics, Inc. Generex Biotechnology Gilead/Nexstar Glaxo Wellcome Guilford Pharmaceuticals, Inc. ICN/Senetek Imarx Inhale Therapeutics Insite Vision, Inc. IOMED IVAX Corp. Key Pharmaceuticals/Schering KOS KV Pharmaceuticals LAM Pharmaceuticals Lectec Corp. The Liposome Co. Macrochem Corp. Macromed, Inc. Matrix Pharmaceutical, Inc. Mediject Meridian Minimed NMP Nastech Pharmaceutical Co., Inc.

  7. Key Market Participants (cont’d) Neopharm, Inc. Nexmed, Inc. Nova Nordisk Pharmaceuticals, Inc. Novartis Pharmaceuticals Corp. Novavax, Inc. Noven Pharmaceuticals, Inc. OraPharma, Inc. Ortho McNeil Penederm/Mylan Penwest Pharmaceuticals Co. Pharmacia Corp. Powderject Pharmaceuticals Purdue Pharma R.P. Scherer, Inc. Robins Roche Rxkinetic Sandia National Laboratories Schering Scinitpharma, Inc. Shire/Pharmavene SkyePharma, Inc. Situs SuperGen/Sparta TAP Techniclone/Peregrine Therapeutic-2000 Transderm Laboratories Transdermal Technologies United Therapeutics Corp. VMPC Vivus, Inc. Watson/Theratech Weston

  8. For More Information • Call tollfree 877 GO FROST (877.463.7876) • Fax tollfree 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com

More Related